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post-chikungunya stage in the epidemic areas. Clinical vig-
ilance is recommended to identify patients with unfavor-
able outcomes 3 months after disease onset and for those 
in whom post-chikungunya chronic inflammatory rheuma-
tism develops and who require specific treatment. Detailed 
guidelines for diagnosis and treatment of these patients 
with chronic rheumatoid arthritis are needed.
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To the Editor: Human monocytic ehrlichiosis (HME), 
a tickborne zoonosis caused by the rickettsial pathogen 
Ehrlichia chaffeensis (Rickettsiales: Anaplasmataceae), 
is considered an emerging pathogen in the United States 
and, increasingly, in many countries around the world (1). 
In Costa Rica, past reports of human cases of ehrlichiosis 
were diagnosed solely by clinical evaluation and cytomor-
phology (2,3); recent studies have detected E. canis in dogs 
and their ectoparasites (4,5). However, molecular detection 
of natural Ehrlichia infection detected in humans in Costa 
Rica has not been reported.
In a small rural area of Zarcero, province of Alajuela, 
north central region of Costa Rica, blood samples were 
drawn from 20 patients who had histories of tick bites and 
nonspecific symptoms of fatigue, arthralgia, and myalgia 
beginning >1 year before sampling. The samples were re-
ferred for Ehrlichia molecular analysis. In addition, blood 
samples were drawn from 2 patients of 2 health care clinics 
in the Alajuela province districts of San Carlos and Ala-
juela who had clinical signs compatible with recent eh-
rlichiosis; the samples were sent for confirmation by PCR. 
All anticoagulated samples were transported within 4 hours 
to the laboratory for processing. No serologic assays were 
performed; cytomorphologic estimation and laboratory 
data were provided from the local health facilities, mostly 
generated 1 year before this molecular analysis. 
DNA was isolated the same day of sampling from 
whole blood (200 μL) by using the QIAamp Blood Kit 
(QIAGEN, Santa Clarita, CA, USA) according to the man-
ufacturer’s instructions. Purified DNA from each blood 
sample was quantified by spectrophotometry, yielding 20–
32 ng/μL of DNA. Nested PCR assays were performed as 
described (6,7). To avoid DNA contamination, first PCR, 
second PCR, and electrophoresis were performed in sepa-
rate rooms, following strict rules of pipetting and clean-
ing, and repeated >3 times. In addition, endpoint PCR for 
the variable-length PCR target gene was performed on 
samples that were positive in the nested assay, according 
to Paddock et al. (8). For DNA sequencing, PCR reactions 
were performed, and products were separated by agarose 
gel electrophoresis. A nested PCR mixture containing wa-
ter and 1 containing unrelated Brucella abortus DNA were 
used as negative controls in every assay. As an internal 
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control, the 22 samples were assayed for the β-globin gene 
(TaKaRa Bio/Clontech, Mountain View, CA, USA). All 
samples were positive for the β-globin gene by PCR with 
primers PC04 and GH20. Fragments (bands) were excised 
from electrophoretic gels by using sterile scalpels. These 
fragments were then were placed in a PCR mixture and 
used as a template.  PCR mixtures were pooled and pu-
rified by using the QIAquick PCR Purification Kit (QIA-
GEN) according to the manufacturer’s instructions. DNA 
was sequenced at Macrogen Inc. (Seoul, South Korea). The 
sequences obtained were compared to those previously de-
posited in GenBank.
Three of the 20 human blood samples from Zarcero 
that were tested, and the 2 samples from patients of dif-
ferent locations, were positive for 16S rRNA gene frag-
ment of 390 bp and showed  99%–100% identity to the 
E. chaffeensis strain Arkansas gene (GenBank accession 
no. NR074500.1). These fragments were sequenced and 
deposited in GenBank, under accession numbers CR1 
San Carlos (KF888343), CR2 Alajuela (KF888344), CR3 
Zarcero (KF888345), CR4 Zarcero (KF888346), and CR5 
Zarcero (KF888347). Amplifed bands for 2 of the 5 sam-
ples positive by nested PCR (CR1 and CR4) were identical 
to those specific for the 5 repeats of variable-length PCR 
target gene (459 bp). 
A summary of clinical manifestations and results of 
DNA analysis is shown in the Table. The major symp-
toms reported by most patients were rash, predominantly 
macular in extremities; general arthralgia and myalgia; and 
headache. Comparison of clinical and laboratory findings 
of patients with PCR-positive and -negative results showed 
no clear differences, possibly related to the length of time 
between the acute phase of illness and the sampling for mo-
lecular analysis, which was usually 1 year. Nevertheless, it 
is noteworthy that the patients’ samples harbored detect-
able Ehrlichia DNA 1 year after the acute phase, which was 
similar to findings in recent reports (9). Equally, related 
to the 2 patients evaluated in this study who had a recent 
history of infection (CR1 and CR2), no major physical 
or biochemical alterations were observed, suggesting that 
disease manifestation was mild or that samples were taken 
during the convalescent phase. The incongruent high detec-
tion of intracellular morulae and low PCR results point out 
the necessity of improving techniques for early diagnosis 
of this disease, particularly in primary health care clinics. 
Clinicians and public health authorities should be aware of 
the presence of this pathogen in the region and should in-
clude molecular tools in the diagnosis of this zoonosis.
The arthropod vector or vectors, and vertebrate res-
ervoir or reservoirs of E. chaffeensis in Costa Rica are 
unknown, and further ecologic studies are required to de-
termine these aspects of human monocytic ehrlichiosis in 
Central America. Epidemiologic and ecologic surveys are 
needed to trace and control the dissemination of this public 
health threat.
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Table. Clinical manifestations in patients and laboratory findings of Ehrlichia PCR-positive and negative blood samples, Costa Rica 
Characteristics Patient group, no. (%) 
Clinical findings at first examination PCR-positive, n = 5 PCR-negative, n = 17 
 History of tick bite 5 (100) 12 (70.6) 
 Fever 2 (40) 1 (6) 
 Rash 4 (80) 11 (64.7) 
 General arthralgia 5 (100) 11 (64.7) 
 Headache 4 (80) 7 (41.2) 
 Detection of morulae 1 (20) 12 (70.6) 
 Positive response to doxycycline 1 (20) 8 (47.1) 
Laboratory findings  Range (reference value)* 
 Leukocytes 5.3–7.9 × 109 cells/L (5–10 × 109 cells/L) 6.0–8.9 × 109 cells/L (5–10 × 109 cells/L) 
 Platelets 190–299 × 109 cells/L (150–450 × 109 cells/L) 217–329 × 109 cells/L(150–450 × 109 cells/L) 
 Hemoglobin 12.9–14.9 (12.5–17 g/dL) 12.7–16.1 (12.5–17 g/dL) 
 Aspartate aminotransferase 27–39 U/L (13–39 U/L) 26–36 U/L (13–39 U/L) 
 Alanine transaminase 21–49 U/L (7–52 U/L) 25–41 U/L (7–52 U/L) 
*Laboratory values at time of sampling for this study.  
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To the Editor: Tuberculosis caused by bacteria of the 
Mycobacterium tuberculosis complex affects humans and 
various species of captive and free-living wildlife (1). In 
addition, M. tuberculosis has been used experimentally in 
many different species of Old World monkeys as part of 
the attempt to establish a suitable model for human tuber-
culosis (2). We report a case of disseminated tuberculosis 
caused by M. tuberculosis Spoligotype International Type 
(SIT) 52 in a recently imported sooty mangabey (Cercoce-
bus atys) from South Africa to Thailand.
A juvenile male sooty mangabey was imported from 
South Africa to Thailand in September 2009. Within 1 
week, while in quarantine, convulsion and salivation 
developed in the mangabey, and it died suddenly. This 
animal, along with another mangabey and 4 mustached 
guenons (Cercopithecus cephus), was imported from its 
native Africa to Thailand for the pet trade. Complete his-
tories of the second mangabey and the mustached guenons 
were not available.
A complete necropsy of the dead sooty mangabey was 
conducted, and full histopathologic and microbiological 
analysis was performed. At necropsy, the mangabey was 
emaciated, with no subcutaneous and abdominal fat tis-
sues. Disseminated granulomas (up to 2 cm) were observed 
throughout the carcass, including the lungs, liver, spleen, 
kidneys, multiple lymph nodes (hilar, mediastinal, mesen-
teric, splenic, hepatic, renal, and pancreatic), and the ileum. 
The lung was also multifocally adhered to the thoracic wall 
and pleural diaphragm.
Histologically, the granulomas in all tissues examined 
demonstrated similar histopathologic features, character-
ized by a central core of caseous necrosis and surrounded 
by an unorganized rim of mixed inflammatory cells, includ-
ing neutrophils, lymphocytes, plasma cells, and epithelioid 
macrophages. Numerous acid-fast bacilli were present in 
the cytoplasm of the epithelioid macrophages and in the 
necrotic area of all tissues. Acid-fast bacilli were isolated 
and classified as M. tuberculosis on the basis of 1-tube mul-
tiplex PCR (3) and sequencing of 16S rRNA gene results. 
Spoligotyping revealed that the M. tuberculosis isolate be-
longed to SIT 52.
The international wildlife trade had been reported to 
be a major source of imported zoonoses, particularly tu-
berculosis, in nonhuman primates (4–8). In the mangabey 
reported here, fulminant tuberculosis was diagnosed with-
in 1 week after it arrived in Thailand, during the 21-day 
quarantine period. The granulomas were morphologically 
similar to the histopathologic description of tuberculosis 
lesions of experimentally infected cynomolgus macaques 
(Macaca fascicularis), which demonstrated lesions as 
early as 3 weeks after infection, with a gradual increase 
in severity (2). Previously, East African–Indian lineage 
(9) and Beijing spoligotype (SIT 1) accounted for most 
M. tuberculosis isolates in Thailand (10). In nonhuman 
primates in Thailand, M. tuberculosis complex had been 
detected at rates of up to 50% (5 positive samples from 
10 test samples) by PCR from buccal swabs in long-tailed 
macaque (Macaca fascicularis) (1). M. tuberculosis be-
longing to SIT 52 observed in this case has been primar-
ily isolated from countries in Africa (9). Only 1 case of 
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